Month: May 2025

WILMINGTON, Del., May 27, 2025 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company will be presenting at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3rd, 2025, at 4:20 PM ET. The event will be webcast live and an archived replay of the presentation will also be available following the conference. For more information, please visit the Investors section of the company’s website closer to the event. About InterDigital® InterDigital is a global research and development company focused primarily on wireless, video, artificial intelligence (“AI”), and related technologies. We design and develop foundational technologies that enable connected, immersive experiences in a broad range of communications and entertainment...

DSMB recommended the continuation of trial as planned Topline data expected in Q3 2025 NEW HAVEN, Conn., May 27, 2025 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that an independent Data Safety Monitoring Board (DSMB) recommended that the SERENITY At-Home pivotal Phase 3 safety trial of BXCL501 for acute treatment of agitation associated with bipolar disorders or schizophrenia continue without modification. The DSMB recommendation followed a review of unblinded safety data from the first 115 patients dosed as of the May 2, 2025 cutoff date. The trial is fully enrolled and collection of data over the 12-week period is continuing. “We are pleased with the favorable DSMB meeting outcome...

Billings, MT, May 27, 2025 (GLOBE NEWSWIRE) — Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock and organic waste treatment and resource recovery technology, announced it has received the first Letters of Interest (LOI) for its OMRI (Organic Materials Research Institute) Listed nitrogen fertilizer, from two of the largest distributors of organic fertilizers on the West Coast. Perfect Blend has executed an LOI for 50,000 gallons at $7.00 per pound, FOB (Freight on Board) at Bion’s initial fertilizer production facility (location to be determined).  Perfect Blend’s headquarters are in Bellevue, Washington, and they have offices across the USA and increasingly in places around the world. They lead in the research, development, and manufacturing of focused nutrition biological fertilizers and are...

TAMPA, Fla., May 27, 2025 (GLOBE NEWSWIRE) — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis consumer packaged goods company and retailer, today announced it will report financial results for the first quarter ended March 31, 2025, on Thursday, May 29, 2025. The Company will host a conference call and live audio webcast to discuss the financial results and provide investors with key business highlights. The company will issue a press release with its results prior to the call. CONFERENCE CALL DETAILSEvent: FLUENT Corp. First Quarter 2025 Financial Results Call   Date: Thursday, May 29, 2025   Time: 4:30 p.m. Eastern Time   Webcast Link: FLUENT Corp Conference Call   Dial-In Number: 1-844-763-8274 (toll -free) 1-412-717-9224 (international)   Join...

Certification Underscores OPT’s Commitment to Operational Excellence and Real-World Autonomous Maritime Solutions MONROE TOWNSHIP, N.J., May 27, 2025 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative, cost-effective, low-carbon and artificial intelligence maritime services that enable safer and more productive ocean operations and related power, data, and service solutions, today announced its recognition as one of the initial certified operators under the Association for Uncrewed Vehicle Systems International (AUVSI) Trusted UMS Operator Program. The program, launched by AUVSI in collaboration with leading industry stakeholders, is designed to establish a high standard for training, proficiency, and safety in the operation of uncrewed maritime systems (UMS)....

MAINZ, Germany, May 27, 2025 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology portfolio at the American Society of Clinical Oncology (“ASCO”) Annual Meeting, to be held in Chicago, IL, from May 30 to June 3, 2025. The data highlight continued progress of the Company’s clinical programs consisting of complementary therapeutic modalities, including mRNA cancer immunotherapies, next-generation immunomodulators, and targeted therapies, including antibody-drug conjugates (“ADCs”). “We believe that the next era of cancer medicine will be defined by the interplay of complementary mechanisms and innovative molecules, unlocking their full potential through synergy. Our data presentations at this year’s ASCO Annual Meeting...